The contract manufacturing space has gone from strength to strength in the last ten years and in an increasingly crowded marketplace, selecting the right contract partner is more important than ever before.
Growth in the emerging pharmaceutical sector, particularly in the US, is driving demand for contract services such as manufacturing capabilities. Added to this, pharmaceutical companies are divesting their internal capabilities to generate cost-savings and instead opting for outsourced services.
In this month’s Pharma Technology Focus our CEO, Kevin Cook discusses how CDMOs can take advantage of the market growth and differentiate their offering. Read the full roundtable here: http://bit.ly/2vLlCFj.